ArticleF1000Research2016
Possible repurposing of seasonal influenza vaccine for prevention of Zika virus infection.
Article in F1000Research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 9 citations in OpenAlex.
- The Zika virus: Lurking behind the COVID-19 pandemic?Journal of clinical pharmacy and therapeutics · 2021Review
- Prevention and Control Strategies to Counter Zika Virus, a Special Focus on Intervention Approaches against Vector Mosquitoes-Current Updates.Frontiers in microbiology · 2018Review
- Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infections.JCI insight · 2017Article
- Drug Repositioning in the Mirror of Patenting: Surveying and Mining Uncharted Territory.Frontiers in pharmacology · 2017Article
- The Anti-helminthic Compound Mebendazole Has Multiple Antifungal Effects againstFrontiers in microbiology · 2017Article
- Prediction of influenza vaccine effectiveness for the influenza season 2017/18 in the US.F1000Research · 2017Article
- Possible repurposing of seasonal influenza vaccine for prevention of Zika virus infection.F1000Research · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The in silico analysis shows that the envelope glycoproteins E of Zika viruses (ZIKV) isolated in Asia, Africa and South and Central America encode highly conserved information determining their interacting profile and immunological properties. Previously it was shown that the same information is encoded in the primary structure of the hemagglutinin subunit 1 (HA1) from pdmH1N1 influenza A virus. This similarity suggests possible repurposing of the seasonal influenza vaccine containing pdmH1N1 component for prevention of the ZIKV infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.